AYAL Capital Advisors »

Charles River Laboratories shares owned by AYAL Capital Advisors

Quarter-by-quarter ownership of Charles River Laboratories (CRL) shares owned by AYAL Capital Advisors from 13F filings

Historical chart of AYAL Capital Advisors investment in Charles River Laboratories

Tip: Access up to 7 years of quarterly data

All positions including Charles River Laboratories held by AYAL Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Charles River Laboratories by AYAL Capital Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.7M 28k 236.40

More positions owned by AYAL Capital Advisors

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Arcosa (ACA)
Investment Managers Ser Tr I Axs Short Innov Call Option (SARK)
MDU Resources (MDU)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Fluor Corporation (FLR)
Charles River Laboratories (CRL)
Orthofix Medical (OFIX)
Celestica Sub Vtg Shs Put Option (CLS)
Stoneridge (SRI)
MasTec (MTZ)
Harsco Corporation (NVRI)
Phinia (PHIN)
Petiq Com Cl A (PETQ)
Cavco Industries (CVCO)

View all positions for AYAL Capital Advisors

Top funds holding Charles River Laboratories

Vanguard Group
ClearBridge Advisors
T. Rowe Price Associates
Meritage Group
Allspring Global Investments Holdings
Southpoint Capital Advisors
Mackenzie Financial
Earnest Partners
Franklin Resources
Bank of America Corporation
Sei Investments
Wells Fargo & Company
Charles Schwab Investment Management
Montrusco Bolton Investment
Dimensional Fund Advisors

View all funds holding Charles River Laboratories